LITTLE FALLS, N.J.,
Sept. 19, 2013 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN) will
release the results for its fourth quarter ended July 31, 2013 on Thursday,
September 26 before the market opens, and hold a conference
call to discuss the results at 11:00 AM
EDT. Participating in the call will be Charles M. Diker, Chairman; Andrew A. Krakauer, President and CEO;
Jorgen B. Hansen, Executive Vice
President and COO; Craig A. Sheldon,
Senior Vice President, CFO and Treasurer; and Seth Yellin, Senior Vice President-Corporate
Development.
To participate in the conference call, dial (877) 407-8033
approximately 5 to 10 minutes before the beginning of the call. If
you are unable to participate, a digital replay of the call will be
available from Thursday, September 26,
2013 through midnight on November 26,
2013 by dialing (877) 660-6853 and using conference ID #
100313.
The call will be simultaneously broadcast live over the Internet
on vcall.com at
http://www.investorcalendar.com/IC/CEPage.asp?ID=171627. A replay
of the webcast will be available for 90 days on Vcall and via the
investor relations page of the Cantel web site.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:
CMN) is a leading provider of infection prevention and control
products in the healthcare market. Our products include water
purification equipment, sterilants, disinfectants and cleaners,
specialized medical device reprocessing systems for endoscopy and
renal dialysis, disposable infection control products primarily for
dental and GI endoscopy markets, dialysate concentrates and other
dialysis supplies, hollow fiber membrane filtration and separation
products for medical and non-medical applications, and specialty
packaging for infectious and biological specimens. We also provide
technical maintenance for our products and offer compliance
training services for the transport of infectious and biological
specimens. For further information, visit the Cantel website
at www.cantelmedical.com.
SOURCE Cantel Medical Corp.